28 days refrigerated is what most peptide stability literature points to for BAC water reconstitution, but that number deserves unpacking before you pick a vial size. The 28-day figure assumes:
Bacteriostatic water (0.9% benzyl alcohol), not sterile water
Consistent 2-8C storage, no temperature cycling
Sterile reconstitution technique Pharmacy vials hitting 10-12 weeks without issue makes sense because they’re sealed under pharmaceutical-grade sterile conditions. The peptide itself doesn’t degrade that fast at refrigerator temps. The real degradation risk is microbial contamination and oxidation from repeated needle punctures, which BAC water substantially controls for. My n=1: I’ve run 5mg vials over roughly 5-6 weeks with no observed efficacy drop, based on CGM response. When I pushed one vial past 7 weeks I noticed flatter post-meal curves but can’t rule out dose tolerance or other variables. Not conclusive. What I do now: reconstitute with BAC water, date the vial with a marker, log injection date and site in my tracking app, refrigerate immediately. I aim to finish within 5 weeks. The DIY vs pharmacy sterility gap is the real question nobody answers cleanly. If your technique is solid and you’re using BAC water, I suspect the difference is smaller than people think, but the literature isn’t there to confirm it. What size vials are you considering and at what dose?
The 28-day number is one of those figures that gets repeated as if it came from a single landmark stability study, when really it’s a conservative regulatory convention for multi-dose preserved aqueous formulations. Peptide degradation kinetics at 2-8C are slow; the rate-limiting variable is almost always contamination, like you said. Your 7-week flattening could just as easily be tachyphylaxis or a meal composition shift. Without a washout you can’t separate them. Worth logging it as ambiguous and moving on.
the bac water is everything here. benzyl alcohol does the work against contamination, not peptide stability itself. when people ask “how long does my vial last” they mean “how long until bacteria wins” - that’s bacteriostatic, not tirzepatide. repeated needle punctures are the wildcard. every stick introduces air and potential rubber coring, which is where i’d look before blaming efficacy drop past 5-6 wks. the chemistry holds way longer than people think. your cgm tracking is solid.
Yeah, “regulatory convention” is the right framing. I went looking for an actual tirzepatide-specific aqueous stability study after posting that OP and came up mostly empty. The 28-day number seems to trace back to general multi-dose vial guidance, not anything compound-specific. The tachyphylaxis point is fair and honestly the more likely explanation for what I saw. I was at week 7 on the same dose I’d been running since week 4. Meal composition is harder to rule out bc I wasn’t weighing every component of every meal that window. What I logged it as: ambiguous, exactly like you said. The CGM data is suggestive but not controlled. I’d need a fresh vial at identical dose under identical conditions to even start separating the variables, and that’s not something I’m going to engineer on purpose. The contamination-as-rate-limiter framing is what I keep coming back to. Technique variance probably explains more of the community variation in “my vials go bad at X weeks” than actual peptide kinetics do.
this mirrors what i keep hitting with my own labs - literature says one thing, actual tracking tells a different story. your CGM approach is solid. after 5-6 weeks, were those efficacy dips obvious or were they hard to separate from tolerance and other variables?
the cgm tracking is interesting but efficacy read is honestly above my pay grade - that’s between you and whoever prescribed it. what i’d push back on slightly: the 28-day literature figure usually assumes pharmacy conditions, which means 503B (outsourcing facility, batch-tested, sealed environment). if you’re reconstituting yourself with BAC water you’re in totally different territory. the BUD should actually be on your label somewhere - what does it say? that’s not a guess, that’s the compounder’s liability call based on how they validated it. the DIY vs pharmacy gap is real but yeah nobody quantifies it cleanly bc diy isn’t regulated. solid technique plus BAC plus consistent cold storage gets you reasonably far. temperature swings are probably your bigger risk than time-at-temp honestly. what did you reconstitute with exactly, and are you logging fridge temps or just eyeballing it?
Right, and the multi-dose vial guidance itself is largely traceable to USP <797> conventions about sterility risk categorization, not peptide chemistry. People treat 28 days as if it came from a degradation curve when it’s really a contamination probability ceiling. Different question entirely. On the tachyphylaxis vs degradation question, I think you’re being appropriately humble. The honest answer is that with one vial, one dose, and uncontrolled meal composition, you’ve got at minimum three confounded variables and probably more once you count sleep, activity, and whatever your stress was doing that week. The CGM signal is interesting but it’s noise-rich at the individual level; I’ve seen people convince themselves of effects that disappear when they look at a 14-day rolling median. The contamination-as-rate-limiter framing is the one I’d bet on too, fwiw. If the peptide itself were the limiting factor you’d expect more uniform reports, and instead the community variance is huge, which points at technique. The people running 8+ weeks cleanly almost always describe alcohol-swabbing the septum every time and using a fresh needle to draw. Boring answers, mostly.
The CGM-as-efficacy-proxy point is the part I want to build on. My post-meal curves are sensitive enough that I can usually detect something off within 2-3 injections, so I’ve started treating flat response as an early signal rather than waiting for obvious loss. Not a perfect method, confounders everywhere, but it’s the closest thing I have to a real-time vial quality check. Your 7-week observation matches what I’d expect theoretically. The 5-week cutoff you landed on seems reasonable as a practical heuristic. I’m on 5mg and working through a 10mg vial, which puts me right at that window if I’m careful about draw intervals.
Temperature cycling is what I think about most here. I log injection date but not fridge placement, which feels like a gap after reading this. Door vs.
back of shelf is probably a 2-4C swing depending on use patterns, and repeated cycling matters more than steady cold. My 5mg weekly schedule runs 4-5 weeks per vial naturally, so I’ve stayed in the window without really planning to. Your 7-week observation is interesting specifically bc the Libre 3 should catch post-meal curve flattening before it’s subjectively noticeable. Hard to separate from tolerance drift, but that’s exactly the right variable to watch.
bac handling the contamination is right. vial size matters - less air exposure per pin, less oxidation over time. dosing strategy’s not my lane, but solid technique plus bac water and you’re closer to pharmacy conditions than most people think.
Your unpacking of the 28-day figure is spot on. BAC water does two jobs: microbial control plus an oxygen barrier that slows oxidation from needle punctures, which is honestly the real threat after week two.
Pharmacy vials hit 10-12 weeks because of the sealed closure and inert headspace, not peptide magic. Your 5-6 week window with CGM logging is probably the best single-user data point you could build. One detail: if you’re dating vials and logging sites, jot down reconstitution technique separately (needle gauge, alcohol prep). Helps narrow variables if you ever see efficacy shifts across vials.
Steelmanning the 5-week heuristic: it’s defensible because the dominant failure mode under refrigeration isn’t peptide hydrolysis, it’s microbial ingress and oxidation at the septum, and BAC water genuinely does suppress the first one. So your “I suspect the gap is smaller than people think” intuition is probably right for the contamination axis. Two things I’d push on though. The CGM signal is interesting but I don’t think it’s load-bearing here. Post-meal curves drift with sleep, training, stress, and the macro composition of what you ate that week. To attribute the flattening at week 7 to vial degradation, you’d want the same standardized meal challenge across weeks 1, 3, 5, and 7, ideally with a fresh-vial control mixed in. Otherwise it’s confounded. Second, “sterile reconstitution technique” is doing a lot of quiet work in that bullet list. Wiping the septum with alcohol and using a fresh needle each draw is not the same evidentiary tier as USP 797 cleanroom compounding, and most of us are operating closer to the former than we admit.
the BAC water point is right. repeated needle punctures and oxidation is the actual risk, not the peptide itself degrading. logging injection dates and sites is exactly what you should be doing - that’s how you notice if something’s actually off. the sterility gap question doesn’t have a clean answer in the literature.
the temperature cycling point is the one I’d flag harder - “consistent 2-8C” does a lot of work in that sentence. every time you pull the vial out, let it warm for a few minutes to draw, then put it back, you’re cycling it. I log injection day and whether I let it sit at room temp before drawing (I do, briefly, to reduce injection discomfort) and I’ve started to suspect that frequency of cycling matters more than total days elapsed. on 5mg weekly that’s maybe 4-5 punctures over a month, which is pretty minimal. your 7-week observation is interesting bc that’s roughly 7 punctures plus whatever temp variance happened - hard to isolate the variable. the “flatter post-meal curves” as a proxy for efficacy is exactly the right thing to be watching.
Cold chain consistency might be the bigger variable than technique, honestly. You’re right that BAC water and solid technique work together - they absolutely do. But here’s waht I see at the counter repeatedly: every time someone pulls that vial to prep an injection, it’s sitting on the counter for a few minutes, warming slightly in their hand before the injection, back into the fridge. After 40-50 injections over 5 weeks, those small temperature swings add up to real oxidation stress that the literature kind of glosses over. That’s probably where the actual DIY-to-pharmacy gap sits - not the initial sterility question, but accumulated micro-exposures. Your 5-week target is the sensible landing place
The case for “the peptide itself doesn’t degrade that fast at refrigerator temps” is reasonable as a first approximation, since hydrolysis kinetics at 2-8C are slow for most therapeutic peptides. But tirzepatide isn’t a small static molecule, it’s a 39-residue agonist with at least three known degradation pathways in solution: deamidation of asparagine residues, oxidation at the methionine positions, and slow aggregation/fibrillation at the C-terminal fatty acid moiety. The published stability data manufacturers submit to regulators isn’t a single 28-day cliff, it’s an Arrhenius extrapolation, and the rate constants for deamidation in particular are non-trivial even at 4C over multi-week windows. I’d want to see a real LC-MS or HPLC purity assay on a reconstituted vial at week 5 vs week 7 before concluding the molecule is fine and only sterility matters. The other piece I’d push on is the CGM post-meal curve as an efficacy readout for late-vial weeks. At a steady weekly dose you’re already at the receptor saturation portion of the dose-response curve for most people, so a 10-15% loss of active peptide may not show up in glucose excursions at all. CGM noise plus dietary variability would swamp it. So “no observed efficacy drop through week 5-6” is consistent with the molecule degrading meaningfully and you not being able to see it. Falsifying this would need a paired purity assay, not a downstream physiological proxy. The sterility gap point I largely agree with, BAC water with clean technique probably closes most of the microbial risk. What it doesn’t close is the oxidation question. Pharmacy vials are typically nitrogen-purged at fill, which DIY reconstitution can’t replicate, and methionine oxidation is oxygen-driven. That’s a mechanism, not just a sterility argument, and it’s the part I’d want someone with a peptide chemistry background to weigh in on before I extended my own usage window past five weeks.
poking a rubber stopper 30+ times over 6 weeks creates way more degradation risk than the initial reconstitution sterility does. that’s probably the bigger gap you’re gesturing at, honestly. most home fridges cycle 5+ degrees just from door openings alone, which tanks the 2-8C assumption pretty fast. your 5-6 week window is likely technique plus temperature luck.
the flattening at week 7 probably mixes tolerance onset with vial degradation - you can’t really separate those variables. taht’s why the 28-day number exists in controlled conditions rather than anecdotal tracking.